Correlation Between Neuropace and ProSomnus, Common

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neuropace and ProSomnus, Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and ProSomnus, Common into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and ProSomnus, Common Stock, you can compare the effects of market volatilities on Neuropace and ProSomnus, Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of ProSomnus, Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and ProSomnus, Common.

Diversification Opportunities for Neuropace and ProSomnus, Common

0.45
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Neuropace and ProSomnus, is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and ProSomnus, Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProSomnus, Common Stock and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with ProSomnus, Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProSomnus, Common Stock has no effect on the direction of Neuropace i.e., Neuropace and ProSomnus, Common go up and down completely randomly.

Pair Corralation between Neuropace and ProSomnus, Common

Given the investment horizon of 90 days Neuropace is expected to generate 3.61 times less return on investment than ProSomnus, Common. But when comparing it to its historical volatility, Neuropace is 8.42 times less risky than ProSomnus, Common. It trades about 0.09 of its potential returns per unit of risk. ProSomnus, Common Stock is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  680.00  in ProSomnus, Common Stock on August 28, 2024 and sell it today you would lose (633.00) from holding ProSomnus, Common Stock or give up 93.09% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy87.88%
ValuesDaily Returns

Neuropace  vs.  ProSomnus, Common Stock

 Performance 
       Timeline  
Neuropace 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.
ProSomnus, Common Stock 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ProSomnus, Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, ProSomnus, Common is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Neuropace and ProSomnus, Common Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neuropace and ProSomnus, Common

The main advantage of trading using opposite Neuropace and ProSomnus, Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, ProSomnus, Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProSomnus, Common will offset losses from the drop in ProSomnus, Common's long position.
The idea behind Neuropace and ProSomnus, Common Stock pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated